Advanced Therapies in the Cold Chain
Advanced therapies do not operate within traditional cold chain systems. Temperature control, timelines, and...
read Details
Entering the U.S. market comes with a unique set of regulatory challenges, particularly when it comes to meeting FDA compliance standards around transport validation and cold chain. For European drug manufacturers, navigating these hurdles is often daunting. Learn how to avoid sleepless nights worrying about compliance missteps, unexpected delays, and the potential risk of product rejection. This webinar will provide insights into the critical areas of transport validation where many manufacturers face challenges and offer practical strategies to mitigate them.
Join Robert Battista, Carson Dickey, and Rachel Sawyer, experts in FDA regulatory compliance and cold chain engineering, as they guide you through the key steps to ensure a successful product launch in the U.S. You’ll gain:
Watch the on-demand webinar now:
Advanced therapies do not operate within traditional cold chain systems. Temperature control, timelines, and...
read Details
Logistics is where advanced therapy programs meet reality. You can have the most precisely...
read Details
Antibody-drug conjugates (ADCs) represent some of the most promising, and most complex, therapies in...
read Details